Rituximab Works in ANCA-Linked Vasculitis - MedPage Today MedPage Today WASHINGTON -- Rituximab given as adjunctive therapy to children with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis dramatically lowered the dosage of cyclophosphamide needed for treatment, a researcher said here. Children who did ... |
